Allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia following nonmyeloablative conditioning using 200-cGy total body irradiation and fludarabine.
Koh
L P
LP
Koh
M B C
MB
Ng
H Y
HY
Hwang
W Y K
WY
Goh
Y T
YT
Linn
Y C
YC
Ng
H J
HJ
Chuah
C T H
CT
Tan
K W
KW
Loh
Y S M
YS
Tan
D C L
DC
Tan
P H C
PH
Tan
P H C
PH
D000328:Adult; D000741:Anemia, Aplastic / Q000150:complications / Q000401:mortality / Q000628:therapy*; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006086:Graft vs Host Disease / Q000209:etiology / Q000401:mortality / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation / Q000401:mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D019653:Myeloablative Agonists / Q000008:administration & dosage*; D036102:Peripheral Blood Stem Cell Transplantation / Q000401:mortality; D012074:Remission Induction; D012189:Retrospective Studies; D012720:Severity of Illness Index; D019172:Transplantation Conditioning / Q000379:methods / Q000401:mortality; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D014916:Whole-Body Irradiation
D019653:Myeloablative Agonists; D014740:Vidarabine; C024352:fludarabine